公告日期：2024-04-28

Stock code: 300759.SZ
Stock code: 3759.HK

2 0 2 4
First Quarterly Results

Disclaimer

The doc u ments , op ini ons and materials presented in this presentatio n (the “Document”) have b een prepared by Pharmaron Beijing Co., Ltd. (康龍化成(北京)新藥技術股份有限公司) (the “Company”) f or use in

presentations by th e Company a nd d oes not constitute a recommendation regard ing the securities of the Co mpany. You f ul ly understand th at th e Document is be ing mad e av a ila ble on a c onf identia l basis and subject to

the f ol lowing prov is io ns . The contents of this Document have not been reviewed by any regula tory authority in any juris d ic tion. Th e d is tribution of this Document in c erta in jurisdictions may be restricted by law, and the

recipients into whose possession this Doc u me nt comes should informthe ms elv es about, and observe such restrictions. By accessing this Document, you are agre ein g (i) that you have read and agree to comply with the

contents of this notice and disclaimer and (ii) to maintain absolute c onf identiality regarding the information disclosed in this Document.

This Document has not been indepe ndently verified and is not int ended to form the basis of any investment decision. It does not constitute an of fer or invitation to sell, or any s olic itat ion of any offer to subscribe for or
purchase any securities in any juris d ic tion in which the making of such of fer, solicitation or sale would be unlawful prior to registration or qualification und er the securities laws of such jurisdiction or would not otherwise

be in compliance with the laws and regulations of such jurisdiction, and not hing contained herein shall form the basis of any investment decision, contract or commitment whatsoever. This Document contains no

informa tion or material which may result in it be ing dee med (1) to be an a dv ertis eme nt, invitation or docume nt containing an adver……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。